Search Results 1791-1800 of 14776 for anti-TNF drugs

1. Tegaserod (Oral Route) Description and Brand Names - Mayo Clinic

   Your doctor will then contact FDA's Division for Drug Information about the emergency IND process at druginfo@fda.hhs.gov. This medicine is available only with ...

2. A COVID Study to Compare Impact of Zinc Supplementation versus Multivitamin to Support Immune Health - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Have a negative Elecsys Anti-SARS-CoV-2 immunoassay antibody test at ...

3. Interferon Beta-1a (Intramuscular Route, Subcutaneous Route) Proper Use - Mayo Clinic

   Do not use any other needle for the prefilled autoinjector pen. Each package of medicine contains a Medication Guide and a sheet called Instructions for Use.

4. Overview - Molecular Neurotherapeutics - Mayo Clinic Research

   D., focuses on the identification and therapeutic intervention of target molecules and cell types for the treatment or prevention of neurodegenerative disorders ...

5. Dimethyl Sulfoxide (Intravesical Route) Description and Brand Names - Mayo Clinic

   Interstitial cystitis is the only human use for dimethyl sulfoxide that is approved by the U.S. Food and Drug Administration (FDA).

6. Brentuximab (Intravenous Route) Precautions - Mayo Clinic

   Men should use an effective form of birth control to avoid pregnancy in sexual partners during treatment and for at least 4 months after the last dose. If you ...

7. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

8. Gefitinib (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

   Participation eligibility · Relapsed or refractory to last anti-MM regimen. · ECOG performance status ≤ 2. · Receiving subsequent treatment after becoming TCR ( ...

10. Teclistamab-Cqyv (Subcutaneous Route) Proper Use - Mayo Clinic

    Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...